Ravshan Ataullakhanov

USPTO Granted Patents = 27 (Patent Applications = 9)

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 8)

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 113(Granted Patents)

Company Filing History:

24 out of 34

Bostongene Corporation

Nearmedic International Limited

patent

Years Active: 2017-2024

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11984200 - Systems and methods for generating, visualizing and classifying molecular functional profiles (2024-05-14),

2. 11915422 - Techniques for determining tissue characteristics using multiplexed immunofluorescence imaging (2024-02-27),

3. 11842797 - Systems and methods for predicting therapy efficacy from normalized biomarker scores (2023-12-12),

4. 11705220 - Systems and methods for identifying cancer treatments from normalized biomarker scores (2023-07-18),

5. 11587642 - Systems and methods for deconvolution of expression data (2023-02-21),

6. 11430545 - Systems and methods for generating, visualizing and classifying molecular functional profiles (2022-08-30),

7. 11373733 - Systems and methods for generating, visualizing and classifying molecular functional profiles (2022-06-28),

8. 11367509 - Systems and methods for generating, visualizing and classifying molecular functional profiles (2022-06-21),

9. 11322226 - Systems and methods for generating, visualizing and classifying molecular functional profiles (2022-05-03),

10. 11315658 - Systems and methods for deconvolution of expression data (2022-04-26),

11. 11302420 - Systems and methods for generating, visualizing and classifying molecular functional profiles (2022-04-12),

12. 11250568 - Techniques for determining tissue characteristics using multiplexed immunofluorescence imaging (2022-02-15),

13. 11004542 - Using subject sequencing data and a database of therapy biomarker distributions to determine therapy impact (2021-05-11),

14. 10835565 - Pharmaceutical compositions having antibacterial, antiviral, and other immunostimulatory activities (2020-11-17),

15. 10720230 - Method for administering a checkpoint blockade therapy to a subject (2020-07-21),

Title: Ravshan Ataullakhanov - Pioneering Inventor from Moscow, RU

Introduction: Ravshan Ataullakhanov is a distinguished inventor hailing from Moscow, Russia, known for his groundbreaking contributions to the field of biotechnology and medical devices.

Latest Patents: Ataullakhanov's most recent patents focus on innovative methods for blood coagulation analysis, revolutionizing the way clotting disorders are diagnosed and treated.

Career Highlights: With a career spanning over two decades, Ataullakhanov has held key positions in leading research institutions and biotech companies, driving forward cutting-edge projects in hematology and coagulation.

Collaborations: Throughout his career, Ataullakhanov has collaborated with renowned scientists, medical professionals, and engineers, fostering a multidisciplinary approach to innovation in healthcare.

Conclusion: Ravshan Ataullakhanov's relentless pursuit of excellence and passion for advancing medical technologies have solidified his reputation as a trailblazer in the field of biotechnology, with his work continuing to inspire future generations of inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.